Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Tabuchi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 17, 2025
Efficacy of compression therapy for prevention of peripheral neuropathy caused by taxane-based chemotherapy: a single-center retrospective observational studyYuko Kanbayashi, Takeshi Ishikawa, Yusuke Tabuchi, et al.
Future Oncology (London, England)|March 23, 2026
Predictors of long-term anamorelin hydrochloride use in patients with cancer cachexia: a single-center real-world retrospective studyYuko Kanbayashi, Takeshi Ishikawa, Hayato Kawachi, et al.
IJU Case Reports|July 3, 2025
A Case of Intraoperative Bladder Rupture During Kidney TransplantationKosuke Ogawa, Yusuke Tabuchi, Takahiro Yamaguchi, et al.
Journal of Pharmaceutical Health Care and Sciences|August 8, 2025
Association between antibody-dependent cellular cytotoxicity activity of antitumor antibodies and infusion reactions: a pharmacovigilance analysis using the Japanese adverse drug event report databaseYusuke Tabuchi, Masayuki Tsujimoto, Yuna Kise, et al.
Scientific Reports|February 8, 2020
Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysisYuko Kanbayashi, Takeshi Ishikawa, Yusuke Tabuchi, et al.
Scientific Reports|January 14, 2021
Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysisYuko Kanbayashi, Koichi Sakaguchi, Fumiya Hongo, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2022
Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimenYusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2018
Predictive factors for taxane acute pain syndrome determined by ordered logistic regression analysisYuko Kanbayashi, Kouichi Sakaguchi, Katsuhiko Nakatsukasa, et al.
Biological & Pharmaceutical Bulletin|July 2, 2023
Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab TherapyYusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, et al.
Medical Oncology (Northwood, London, England)|July 19, 2022
Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trialYuko Kanbayashi, Koichi Sakaguchi, Takeshi Ishikawa, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 17, 2025
Efficacy of compression therapy for prevention of peripheral neuropathy caused by taxane-based chemotherapy: a single-center retrospective observational studyYuko Kanbayashi, Takeshi Ishikawa, Yusuke Tabuchi, et al.
Future Oncology (London, England)|March 23, 2026
Predictors of long-term anamorelin hydrochloride use in patients with cancer cachexia: a single-center real-world retrospective studyYuko Kanbayashi, Takeshi Ishikawa, Hayato Kawachi, et al.
IJU Case Reports|July 3, 2025
A Case of Intraoperative Bladder Rupture During Kidney TransplantationKosuke Ogawa, Yusuke Tabuchi, Takahiro Yamaguchi, et al.
Journal of Pharmaceutical Health Care and Sciences|August 8, 2025
Association between antibody-dependent cellular cytotoxicity activity of antitumor antibodies and infusion reactions: a pharmacovigilance analysis using the Japanese adverse drug event report databaseYusuke Tabuchi, Masayuki Tsujimoto, Yuna Kise, et al.
Scientific Reports|February 8, 2020
Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysisYuko Kanbayashi, Takeshi Ishikawa, Yusuke Tabuchi, et al.
Scientific Reports|January 14, 2021
Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysisYuko Kanbayashi, Koichi Sakaguchi, Fumiya Hongo, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2022
Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimenYusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2018
Predictive factors for taxane acute pain syndrome determined by ordered logistic regression analysisYuko Kanbayashi, Kouichi Sakaguchi, Katsuhiko Nakatsukasa, et al.
Biological & Pharmaceutical Bulletin|July 2, 2023
Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab TherapyYusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, et al.
Medical Oncology (Northwood, London, England)|July 19, 2022
Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trialYuko Kanbayashi, Koichi Sakaguchi, Takeshi Ishikawa, et al.
Pageof 2